🇺🇸 FDA
Patent

US 8378107

Heteroaryl antagonists of prostaglandin D2 receptors

granted A61KA61K31/47A61K45/06

Quick answer

US patent 8378107 (Heteroaryl antagonists of prostaglandin D2 receptors) held by Panmira Pharmaceuticals, LLC expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Panmira Pharmaceuticals, LLC
Grant date
Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/47, A61K45/06, A61P, A61P11/00